EDAP to Present at the Jefferies Global Healthcare Conference

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, has announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Ryan Rhodes will deliver a presentation and conduct one-on-one investor meetings during the conference, scheduled for June 3-5, 2025, in New York City.

Rhodes' presentation is set for Thursday, June 5th, from 4:20-4:50 PM ET. Investors can access both the live and archived webcast of the presentation through the company's website's Investor section or via the provided webcast link.

News Market Reaction

-1.66%

1 alert

-1.66% News Effect

On the day this news was published, EDAP declined 1.66%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

05/27/2025 - 07:00 AM

AUSTIN, Texas, May 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 3-5, 2025, in New York City.

Presentation details:

Date:	Thursday, June 5^th
Time:	4:20-4:50 PM ET
Webcast:	https://wsw.com/webcast/jeff319/edap/1824368

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One^® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ

When is EDAP (EDAP) presenting at the Jefferies Global Healthcare Conference 2025?

EDAP's CEO Ryan Rhodes is scheduled to present on Thursday, June 5th, 2025, from 4:20-4:50 PM ET at the Jefferies Global Healthcare Conference in New York City.

How can I watch EDAP's (EDAP) presentation at the Jefferies Healthcare Conference?

The presentation can be accessed via live and archived webcast through EDAP's website's Investors section or directly at https://wsw.com/webcast/jeff319/edap/1824368.